The FDA Is Recalling Organic Whole and Baby Carrots Linked to a Multi-State E. Coli Outbreak
The Food and Drug Administration (FDA) is recalling several brands of organic whole carrots and organic baby carrots after it ...
New FDA rules for TV drug ads: Simpler language and no distractions
Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...
GlobalData on MSN18h
FDA approves Syndax’s Revuforj to treat leukaemia
The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...
Dietary Supplement Recall Update As FDA Sets Risk Level
A Vitamin B supplement has been recalled due to being incorrectly formulated with niacin rather than niacinamide.
BioPharma Dive13h
Syndax secures FDA OK for new kind of leukemia drug
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...
Benefits Pro14h
Pharmacies lobby FDA for right to keep making weight-loss drugs
Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...
The admitted and investigated drug use in some of Trump’s top picks
President-elect Donald Trump’s Cabinet picks are unique for many reasons. One thing that makes several of them stand out is ...
FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
The agency's openness to a targeted pivotal study shows it’s still willing to consider accelerated clearance for Duchenne ...
Here are 4 biotech stocks that could get a boost from a more open FDA regulatory climate
Biotech-stock investing has one tough test for success - and it's about to get easier ...
Aldeyra Therapeutics Shares Up, FDA to Review New Drug Application
Shares of Aldeyra Therapeutics gained after the Food and Drug Administration accepted the company's resubmitted new drug application for its treatment of dry eye disease for review. The stock rose 11% ...
Renal & Urology News14h
Pan-Amyloid Removal Therapeutic Gets Orphan Drug Status for Systemic Amyloidosis
Preclinical studies have shown AT-02 is able to bind to multiple amyloid types and can induce macrophage mediated amyloid phagocytosis and removal. The Food and Drug Administration has granted Orphan ...
NBC Los Angeles on MSN4h
FDA weighs in on diet drug shortage, creating more confusion about compounding
As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.